Status
Conditions
Treatments
About
To date, two devices to measure nitric oxide lung diffusing capacity (DLNO) are commercially available in Europe. Previous research has shown systematic between-device differences in lung diffusing capacity outcomes in healthy people (Radtke et al. ERJ Open Res. 2021 Sep 13;7(3)). The extent and magnitude of between-device differences in people with lung function impairment and ventilation inhomogeneities is unknown.
Full description
The aim of this project is to compare two commercially available devices that measure lung diffusing capacity for nitric oxide (DLNO) in people with systemic sclerosis and proven interstitial lung disease.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
23 participants in 1 patient group
Loading...
Central trial contact
Thomas Radtke, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal